Begin main content

Call for Feedback: Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration

December 10, 2018
A document related to the project entitled Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration is now available for feedback from all interested stakeholders. Project Call for Feedback Feedback Due By Dual Antiplatelet Therapy Following Percutaneous Coronary In...

New at CADTH - December 2018

December 10, 2018
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Call for Patient Input: filgrastim

November 19, 2018
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. filgrastim Brand name Generic name Manufacture...

New at CADTH - November 2018

November 12, 2018
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.